Indo-Bangla Pharmaceuticals Limited announcements
129 Dhaka Stock Exchange announcements for Indo-Bangla Pharmaceuticals Limited (IBP) since 2018: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2021 (20).
- Sale Declaration of a Sponsor
Md. Bellal Khan one of the Sponsors of the Company, has expressed his intention to sell his entire holdings of 34,48,306 shares of the Company at prevailing market price (in the Block Market) through Stock Exchange (DSE) within next 30 working days.
- Sale Declaration of a Sponsor
Md. Amin-Ur-Rashid one of the Sponsors of the Company, has expressed his intention to sell his entire holdings of 30,75,794 shares of the Company at prevailing market price (in the Public Market) through Stock Exchange (DSE) within next 30 working days.
- Prohibition on providing loan facilities to purchase securities
DSE NEWS: The Stock Brokers and Merchant Bankers are requested to abstain from providing loan facilities to purchase security of Indo-Bangla Pharmaceuticals Limited in between 1st to 30th trading day after change of categorization, with effect from December 26, 2021 as per BSEC Directive No. SEC/CMRRCD/2009-193/177 and BSEC Order No. SEC/CMRRCD/2009-193/178 dated October 27, 2015.
- Category Change
The Company has been placed in 'B' category from existing 'A' category with effect from December 26, 2021 as the Company has approved 4% Cash dividend for all shareholders excluding the sponsors and Directors and 3% Stock Dividend for all General Shareholders and ICB excluding the sponsors and Directors for the year ended on June 30, 2021. Such stock dividend shall be issued subject to approval of the BSEC.
- Resumption after record date
Trading of the shares of the Company will resume on 22.11.2021 after record date.
- Suspension for Record date
Trading of the shares of the Company will remain suspended on record date i.e., 21.11.2021.
- Emphasis of matters
(Continuation news of IBP): The Nomination and Remuneration Committee (NRC), of the company that reviewed all post employee benefits and the policies are under process for final review of the Board. Our opinion is not modified in respect of this matter. (end)
The first part of this announcement is missing from the archive. - Spot News
Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 17.11.2021 to 18.11.2021. Trading of the shares of the Company will remain suspended on record date i.e., 21.11.2021.
- Corrected Record Date, Spot Date and AGM date of the company
Record Date of the company will be 21.11.2021 instead of 17.11.2021; AGM Date will be: 23.12.2021. Time: 11.00 AM. Spot date will be 17.11.2021 and 18.11.2021 instead of 15.11.2021 and 16.11.2021. Therefore, all transaction will be in public/block market on today 15.11.2021 and tomorrow 16.11.2021. All other information will remain unchanged.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.34 for July-September, 2021 as against Tk. 0.33 for July-September, 2020. NOCFPS was Tk. 0.42 for July-September, 2021 as against Tk. 0.23 for July-September, 2020. NAV per share was Tk. 14.63 as on September 30, 2021 and Tk. 14.29 as on June 30, 2021.
- Spot News
Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 15.11.2021 to 16.11.2021. Trading of the shares of the Company will remain suspended on record date i.e., 17.11.2021.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2021 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2021.
- Dividend Declaration
(Cont. of IBP): b. Bonus shares are declared out of accumulated profit. c. Bonus shares are not declared from capital reserve on revaluation reserve or any unrealized gain or out of profit earned prior to incorporation of the company or through reducing paid up capital or through doing anything so that the post dividend retained earnings become negative or a debit balance. (end)
The first part of this announcement is missing from the archive. - Price Limit Open
There will be no price limit on the trading of the shares of the Company today (31.10.2021) following its corporate declaration.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2021 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2021.
- Decision to Land Purchase
The company has informed the Board of Directors has decided to purchased and executed register sale deed for the purchase of land measuring 1.612 acres as 2nd phase at the cost of Tk. 4,20,68,320.00 (including of registration fee and other relevant cost Tk. 45,07,320.00) situated at Fulbaria, Kaliakoir, Gazipur. The purpose of the land is for future expansion of the business and the amount was paid from the own fund of the company.
- Withdrawn the suspension order of DGDA
Referring to their earlier letter no. IBPL/Board secretariat/DSE/news/2021/19 and news disseminated by DSE dated 23.03.2021 regarding suspending the production and marketing of all licensed items of lndo-Bangla Pharmaceuticals Ltd., the Company has informed that the Directorate General of Drug Administration (DGDA) has withdrawn the temporary suspension order of production and marketing of all licensed items by issued memo No. DGDA/ML-032/06/7151 on 12 April 2021.
- Information on temporary ban of company's production and marketing
The company has informed that they have received a letter on March 07, 2021 from Directorate General of Drug Administration for temporary ban of company's production and marketing. Therefore, the company instantly filed a writ petition against the mentioned order. They also informed that final hearing and date of order of honorable Court is scheduled to be held on April 04, 2021.
- Dividend Disbursement
The Company has informed that it has credited the Bonus shares for the year ended on June 30, 2020 to the respective shareholders' BO Accounts and it has also disbursed the cash dividend warrant to the respective shareholders through courier services.
- Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.33 for October-December 2020 as against Tk. 0.44 for October-December 2019; EPS was Tk. 0.66 for July-December 2020 as against Tk. 0.83 for July-December 2019. NOCFPS was Tk. 0.68 for July-December 2020 as against Tk. 0.82 for July-December 2019. NAV per share was Tk. 13.77 as on December 31, 2020 and Tk. 13.61 as on June 30, 2020.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.